Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Business, Policy & Funding › Business News › Precipio Sued Over Transgenomic Securities Agreement

Precipio Sued Over Transgenomic Securities Agreement

Feb 27, 2018
|
staff reporter

NEW YORK (GenomeWeb) – Molecular diagnostics firm Precipio has been sued for more than $2 million by Crede Capital Group over an alleged violation of a securities agreement between the investment group and Transgenomic, which Precipio acquired last year.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Mar
18
Featured Webinar

Molecular Multi-Target Assay Design Coupled with Reflex Testing with SARS-CoV-2 Mutations in Mind

Sponsored by
Thermo Fisher Scientific

Viruses mutate as they strive to thrive in response to selective pressures.

Mar
29
Featured Webinar

Think Globally, Act Locally: The Importance of Coordinated Global and Community Genetic Surveillance Programs

Sponsored by
Thermo Fisher Scientific

Global genetic surveillance is vital for understanding the evolution of viral pathogens and monitoring for changes in transmissibility, virulence, disease pathology, and impact on the efficacy of diagnostic tests, therapeutics, and vaccines.

Mar
31
Featured Webinar

Development and Commercialization of a Novel CRISPR-Based SARS CoV-2 Test

Sponsored by
MilliporeSigma

This webinar will outline the development and commercialization journey of a novel CRISPR-based SARS-CoV-2 test. 

What's Popular?

In Molecular Diagnostics

  1. AMP Survey Finds Significant Decline in Molecular Cancer Testing Due to COVID-19 Pandemic

  2. Walgreens to Sell Labcorp COVID-19 PCR Home Collection Kits Over-the-Counter

  3. SARS-CoV-2 Test Pooling Studies Offer Insights for Implementing, Optimizing Approaches

  4. NeoGenomics Q4 Revenue Grows 18 Percent, CEO to Retire

  5. Hong Kong Team Develops New Prostate Cancer Test Using Spermine

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.